Crunching the numbers for SRTA... Refresh in a moment for the full analysis.
Strata Critical Medical, Inc. (SRTA)
Healthcare
mixed
$4.04
Updated: 2026-04-13
Financial Strength
50
Mixed
Capital Allocation
55
Mixed
Key Findings
+
Strong FCF growth — free cash flow up more than 20% year over year
−
Negative ROIC — business destroying value on invested capital
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Add to Watchlist
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.